Scientific article
OA Policy
English

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

Published inAlzheimer's & Dementia, vol. 15, no. 6, p. 817-827
Publication date2019
Abstract

A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of peripheral small molecule biomarkers. Given that brain pathology precedes clinical symptom onset, we set out to test whether metabolites in blood associated with pathology as indexed by cerebrospinal fluid (CSF) AD biomarkers.

Keywords
  • EMIF-AD
  • Alzheimer's disease
  • Dementia
  • Amyloid
  • Tau
  • CSF
  • Brain volume measurements
  • Cognitive function measurements
  • Metabolomics
  • Biomarkers
Citation (ISO format)
KIM, Min et al. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer’s Disease biomarker discovery cohort. In: Alzheimer’s & Dementia, 2019, vol. 15, n° 6, p. 817–827. doi: 10.1016/j.jalz.2019.03.004
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1552-5260
311views
287downloads

Technical informations

Creation20/05/2019 16:14:00
First validation20/05/2019 16:14:00
Update15/03/2023 21:15:03
Status update15/03/2023 21:14:59
Last indexation31/10/2024 18:00:43
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack